Superficial adenocarcinoma of the esophagus.

OBJECTIVE Experience with treatment and outcome of superficial adenocarcinoma of the esophagus is limited. The purpose of this study was to evaluate the results of surgical management and identify predictors of survival. METHODS Between September 1985 and December 1999, 122 patients underwent resection. Eighty-nine percent were men (mean age 63 +/- 10 years; range 35-83 years). Sixty (49%) patients were in endoscopic surveillance programs and 48 (39%) had the preoperative diagnosis of high-grade dysplasia. Forced expiratory volume in 1 second was less than 2 L in 12 (12%). Seventy-five (61%) patients underwent transhiatal esophagectomy. Pathologic stage was N1 in 8 (7%). Pulmonary complications necessitating reintubation (respiratory failure) occurred in 10 (8%) patients. Time-related survival models were developed for decision-making (preoperative), prognosis (operative), and hospital care (postoperative). RESULTS Operative mortality was 2.5%. Survival at 1, 5, and 10 years was 89%, 77%, and 68%. Preoperative decision-making factors associated with ideal outcome were 1-second forced expiratory volume of more than 2 L, surveillance, preoperative diagnosis of high-grade dysplasia, and planned transhiatal esophagectomy. Prognosis was decreased in younger patients and in those with N1 disease. Postoperative respiratory failure increased mortality. CONCLUSIONS Surgery is the treatment of choice for superficial adenocarcinoma of the esophagus. The ideal patient has a preoperative diagnosis of high-grade dysplasia found at surveillance, good pulmonary function, and undergoes a transhiatal esophagectomy. Discovery of N1 disease or development of postoperative respiratory failure reduces the benefits of surgery.

[1]  L. Gossner,et al.  Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. , 2000, Gastroenterology.

[2]  P. Parrilla,et al.  24‐h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors , 1999, The British journal of surgery.

[3]  Blot Wj,et al.  The changing epidemiology of esophageal cancer. , 1999, Seminars in oncology.

[4]  T. Rice.  Superficial oesophageal carcinoma: is there a need for three-field lymphadenectomy? , 1999, The Lancet.

[5]  R. Taillefer,et al.  Results of the Collis-Nissen gastroplasty in patients with Barrett's esophagus. , 1999, The Annals of thoracic surgery.

[6]  A. Bhattacharyya,et al.  Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus. , 1999, Gastrointestinal endoscopy.

[7]  F. Ramirez,et al.  The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus. , 1999, Gastrointestinal endoscopy.

[8]  N. Kokudo,et al.  Unique distribution patterns of metastatic lymph nodes in patients with superficial carcinoma of the thoracic oesophagus , 1999, The British journal of surgery.

[9]  A. Lindgren,et al.  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.

[10]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[11]  I. Braghetto,et al.  Long-term results of classic antireflux surgery in 152 patients with Barrett's esophagus: clinical, radiologic, endoscopic, manometric, and acid reflux test analysis before and late after operation. , 1998, Surgery.

[12]  L. Gossner,et al.  Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid , 1998 .

[13]  J. Goldblum,et al.  Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. , 1998, The Annals of thoracic surgery.

[14]  S. Medendorp,et al.  Stage II esophageal carcinoma: the significance of T and N. , 1996, The Journal of thoracic and cardiovascular surgery.

[15]  G. Morales,et al.  Conservative treatment versus antireflux surgery in Barrett's oesophagus: Long‐term results of a prospective study , 1996, The British journal of surgery.

[16]  D. Naftel.  Do different investigators sometimes produce different multivariable equations from the same data? , 1994, The Journal of thoracic and cardiovascular surgery.

[17]  A. Barlow,et al.  Barrett's oesophagus: Effect of antireflux surgery on symptom control and development of complications , 1992, The British journal of surgery.

[18]  E. Blackstone,et al.  Recommendations for prophylactic removal of heart valve prostheses. , 1992, The Journal of heart valve disease.

[19]  Malcolm E. Turner,et al.  The Decomposition of Time-Varying Hazard into Phases, Each Incorporating a Separate Stream of Concomitant Information , 1986 .

[20]  E. Blackstone,et al.  Have the results of mitral valve replacement improved? , 1986, The Journal of thoracic and cardiovascular surgery.

[21]  J. Baskerville,et al.  Guided Regression Modeling for Prediction and Exploration of Structure With Many Explanatory Variables , 1982 .

[22]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[23]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[24]  E. G. Hahn,et al.  KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. , 1999, Gastrointestinal endoscopy.

[25]  C. C. Chen,et al.  The bootstrap and identification of prognostic factors via Cox's proportional hazards regression model. , 1985, Statistics in medicine.